Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tiburio Therapeutics Inc.

www.tiburio.com

Latest From Tiburio Therapeutics Inc.

Scrip Asks… What Does 2020 Hold For Biopharma? Part 4: The Patient

From the general to the particular: drug developers are increasingly tailoring therapies to individuals. Driven by important advances in understanding biology as well as new tools to harness big data, industry participants expect significant progress in biopharma’s approach to the patient.

Personalized Medicine Artificial Intelligence
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Tiburio Therapeutics Inc.
  • Senior Management
  • Abraham N Ceesay , CEO, CEO
    Nerissa Kreher, MD, CMO
    Heather Halem, PhD, VP, Research
  • Contact Info
  • Tiburio Therapeutics Inc.
    Phone: (617) 231-6050
    700 Technology Sq.
    2nd Fl.
    Cambridge, MA 02139
    USA
UsernamePublicRestriction

Register